Skip to main content

Table 2 Demographic and clinical data of enrolled patients

From: Giant cell tumor of bone following denosumab treatment: assessment of tumor response using various imaging modalities

Age
Mean ± SD, range30.7 ± 10.2, 48–16 
Sex
 Male736.84%
 Female1263.16%
Disease type
 Primary1578.95%
 Recurrent315.79%
 Metastatic15.26%
Location of primary lesion
 Pelvis/sacrum210.53%
 Lower extremity842.11%
 Upper extremity736.84%
 Spine15.26%
 Scapula15.26%
Pre-denosumab treatment
 None1368.42%
 Surgery315.79%
 Embolization315.79%
Post-denosumab treatment
 None736.84%
 Surgery1157.89%
 Embolization15.26%